The board of directors of Xenetic Biosciences, Inc. on February 29, 2016, appointed Roger D. Kornberg to serve as a member of board of directors. Dr. Kornberg has served on the Scientific Advisory Boards of the following companies: Cocrystal Discovery, Inc. (Chairman), ChromaDex Corporation (Chairman), StemRad, Ltd, Oplon Ltd. (Chairman), and Pacific Biosciences. He has also been a director for the following companies: OphthaliX Inc., Protalix BioTherapeutics, Can-Fite BioPharma Ltd. and Teva Pharmaceutical Industries Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | +4.28% | +0.03% | +13.04% |
May. 22 | Xenetic Biosciences, Inc. Announces Management Resignations | CI |
May. 22 | Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.04% | 5.76M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences, Inc. Appoints Roger D. Kornberg as a Member of its Board of Directors